custom image

Advances in Cancer Immunotherapy

August 17–19, 2020 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change

The next generation of immune cell therapies requires a new generation of analysis tools

A safe, potent, and persistent immune cell product depends on developers mustering the full repertoire of immune cell function; activation, proliferation, cell fate, cytotoxic killing,

immunomodulation, and memory. All of which must be accomplished in the ever-changing, suppressive, and toxic tumor microenvironment. 

Agilent is dedicated to supporting these next-generation therapies, providing key technologies to enable high-efficiency gene editing and assessment of real-time cell function, phenotype, and fate. Used together, this tool bench provides the capability to measure and control immune cell function, thus enabling translational researchers and developers to achieve the necessary level of therapeutic potency and safety. 

“How intracellular metabolic change governs immunity and inflammation”

The past 10 years or so have seen a major resurgence of interest in immunometabolism. In this webinar, Dr. Luke O’Neill will discuss how metabolism is commandeered in both cancer immunotherapy and in host response to viral infection.

The immunotherapy landscape is changing requiring a new class of analysis tools
Achieving durable immuno-therapeutic responses in the midst of a highly diverse and functionally integrated system has raised the bar for live-cell relevant, kinetic and non-perturbing cell based assays.

Accelerate your development with a new set of tools. Download our eBook to learn more.

custom image

Live chat

 "How intracellular metabolic change governs immunity and inflammation", presented by Dr. Luke O'Neill
 Next Generation Solutions for Immune and CAR T Cell Therapy
 Download the “Breakthroughs in Immunotherapy” eBook